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Between March 1989 and July 1990, 13 patients with tracheobronchial cancer were treated by laser
hyperthermia at the National Cancer Center Hospital. A complete response was achieved in 9 pa-
tients (with 9 carcinoma lesions), with no evidence of local recurrence on follow-up ranging from 4
to 29 months. Four patients had a partial response, requiring alternative therapy.
The surface area of the lesions showing complete response was less than 3 cm2. These lesions had
a superficial appearance by bronchoscopic observation. Our experience suggests that laser hyper-
thermia may be a useful alternative to surgical resection in patients with small localized tumors con-
fined within the tracheobronchial wall.
KEY WORDS: ND:YAG Laser, Flexible Bronchoscope with 2 Channels, Malignant Tumor of
Tracheobronchial Tree, Thermister
INTRODUCTION
Hyperthermia therapy has been performed clinically in
combination with radiotherapy for cancer. Interstitial hy-
perthermia in combination with interstitial radiotherapy
is gaining acceptance rapidly as an effective treatment for
recurrent and/or persistentmalignant tumors. Local tumor
control of more than 50% in previously treated patients
and a low incidence of treatment complications (1-3) has
established the clinical usefulness of the technique.
In recent years, contact irradiation by Nd:YAG laser
using a ceramic tip has been performed more frequently
than noncontact irradiation for treating cancer in the gas-
trointestinal tract. The tip is inserted into a cancerous le-
sion and the temperature increased to 42 to 45 at a
relatively low laser power level (3-5W) for 15 to 30 min-
utes, causing tumor destruction.
The temperature range is controlledby a computer sys-
tem. This method of laser hyperthermia can be clinically
applied more safely than ordinary vaporizing laser irradi-
ation not only for radical treatment of early cancer, but
also forrecanalization ofobstructions causedby advanced
cancer in the gastrointestinal tract. The effect of laser hy-
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perthermia is increasedwhen applied in combination with
radiotherapy.
Therapeutic options for treatment of early-stage lung
cancer of the hilar type traditionally have been limited to
surgical resection. The introduction of laser hyperthermia
has provided anew therapeutic alternative to surgery. This
form of therapy may be particularly helpful, because pa-
tients with bronchogenic carcinoma are at risk for the de-
velopment of a subsequent primary lung cancer. Therapy
that potentially preserves lung parenchyma would be of
benefit in the long-term management of these patients.
The following is a brief report on the role of laser hyper-
thermia in the treatment of roentgenographically occult
carcinoma of the tracheobronchial tree.
MATERIALS AND METHODS
Selection of Patients
All patients included in our study had biopsy-proved ma-
lignanttumors involving the tracheobronchial tree.Thecon-
dition ofeach patient was evaluated by a bronchoscopist, a
thoracic surgeon,andan oncologist. Severereduction inpul-
monary and/or cardiac function precluded surgical resec-
tion in each patient. Two operable patients refused surgery,
and they elected to receive laser hyperthermia. Informed160 R. ONO
consentwas obtainedfromeach patient. The individual rea-
sons for patient selection are shown in Table 1.
Source of Light for Irradiation
A medical-grade quartz optical fiber, 10 m long with a
core diameter of 400m was used to transmit the laser
beam through the bronchoscope to the site of endo-
bronchial cancer. The output beam diverged approxi-
mately 100 to 120. The fiber was passed through the
working channel of the flexible fiberoptic bronchoscope
(Olympus BF2TR) so that the distal end protruded from
the tip of the bronchoscope.
Laser light was transmitted to the tumor in all cases by
means ofintralesional implantation ofthe fiberprobe. The
distal tip ofthe optical fiberwas attached to a3-mm cone-
shaped ceramic probe. To keep a distance between the
cone rod probe and therrnister, they were inserted through
separate channels of a double channel bronchoscope, as
shown in Figure 1.
The thermisterwas placed 5mm from the treatment site
to keep the temperature ofthe lesion at42C + 1.0C, and
a period of20 to 30 minutes was set as one course of treat-
ment. The laser beam initially was in continuous wave
mode until the temperature reached 42C, at which point
the mode automatically changed to pulse wave mode.
In this way, an intense spot with a diameter of 10 rnm
could be obtained. The light dose rate was estimated in
terms ofpower density during interstitial(i) treatment (in
W/cm). The delivered dose was the total dose delivered
interstitially (i) (in Joules/cm). This value was estimated
to be the total amount of light delivered to the whole area.
The proximal end of the optical fiber was attached to a
positioning device thatwas coupled to a continuous wave
or pulse wave Nd:YAG laser (Pentax Model SLY-2). The
wave length produced with the Nd:YAG laser was 1015
nm in all patients. Laser pulses were delivered for 0.1 to
9.9 seconds at 2 to 100 W/pulse.
The thermister containing a thermometer was 2.2 mm
in diameter and was situated in the apex of the apparatus.
The thermister thermometer signal was transmitted to the
thermocontroller to allow function with the shutters
on/off, on the basis ofthermosettlement. This wouldallow
Table 1 Individual reasons for patients selection
beam regulation for the inner part of the tumor. The ther-
mal recorder recorded temperature as a graph. The ther-
mister thermometer was passed through the open channel
of the flexible fiberoptic bronchoscope so that the distal
end protruded from the tip of the bronchoscope.
Treatment
All patients were orally intubated over a flexible fiberop-
tic bronchoscope, and 2% lidocaine anesthesia was ad-
ministered to the lower airways as needed. Photographs
were taken before treatment and at the time of each sub-
sequentbronchoscopic procedure. Eitherbiopsy orbrush-
ing was performed several days before the treatment.
Forthe tumors treatedwith intralesional insertion ofthe
fiber probe, the corresponding ranges were 2 to 3W and
1003 to 3832 J/cm.
The selection ofpower and energy density was initially
based on early clinical data from intralesional laser treat-
mentofmetastatic skin lesions. The datareportedby Tajiri
et al and Suzuki et al from in vivo and in vitro animal ex-
periments influenced us to reduce power densities to de-
crease the possibility of hyperthermic effects (5, 6).
Tumors with substantialbulkthatprotruded into thelumen
were treated with intralesional insertion of the laser fiber.
Since this study most patients had lesions with protrusion
into the lumen, therefore, only intralesional insertion of
the laser fiber was used.
Follow-Up and Interpretation of Results
All the patients understood the need for close follow-up,
including multiple bronchoscopic procedures, to maintain
the therapeutic response. We routinely did a clean-up
bronchoscopic procedure 1 or 2 days after each therapeu-
tic session. The patients also underwent bronchoscopy at
2 to 3 month intervals for at least 3 years after demon-
stration of an initial complete response.
The patients were classified as having a complete re-
sponse if on follow-up evaluation for 4 weeks or longer,
no tumor was found on chest roentgenogram and bron-
choscopy with negative biopsy and brushings. A partial
response was defined as a persistent tumor on follow-up
chest roentgenography or bronchoscopic examination.
Reason No. ofPatients RESULTS
Poor respiratory function 4
Cardiac disease 4
Multiple primary malignant lesions 3
Surgical operation refused and
they selected laser hyperthermia 2
Total: 13
During this study, 13 patients received laser hyperthermia
at National Cancer Center Hospital. All except one had
squamous cell carcinoma. One patient was a woman, and
the other 12 patients were men (age range, 36-79 years;
mean, 64.7 years).BRONCHOSCOPIC LASER HYPERTHERMIA 161
LASERTHERMI A SYSTEM
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Figure I Schematic Diagram of Laserthermia System
The results were categorized according to the thera-
peutic response after laser hyperthermia, subsequent be-
havior of the tumor, long-term results, and the current
status of each patient recorded as of June 1992.
Complete Response
Table 2 presents information on 9 patients who had a
complete response after laser hyperthermia. Eight pa-
tients had squamous cell carcinoma, and the remaining
patient (case 2) had an adenocarcinoma. In two patients
(cases 1 and 6), the response was complete after a single
course of treatment, whereas in three patients (cases 3,
4, and 5), a second laser hyperthermia session was re-
quired to achieve a complete response. For the remain-
ing four patients (cases 2, 7, 8, and 9), a third laser
hyperthermia session was necessary for a complete re-
sponse. In these nine patients, there was no evidence of
local recurrence, with a follow-up period ranging from
4 to 29 months (mean, 19.2 months). Three patients
(cases 1, 2, and 6) who had a complete response subse-
quently died. One patient (case 6) died of a second lung
cancer (small cell carcinoma). At postmortem examina-
tion, no evidence ofresidual cancer was found at the site
of the first cancer. Two patients (cases 1 and 2) were
found at autopsy to have evidence of widespread
metastatic cancer, without evidence of recurrence at the
treated site. The remaining six patients (cases 3, 4, 5, 7,
8, and 9) are still alive and disease-free with a follow-up
ranging from 23 to 29 months (mean, 25.8 months).
Figure 2 shows the bronchoscopic findings of case 3
before and after laser hyperthermia. This case was a flat
superficial tumor. In the first treatment, the probe was
inserted at point (A) and the thermister was placed at
point (B), and hyperthermia was performed for 30 min-
utes, whereas in the second 30-minute procedure, the
probe was inserted in (B) and thermister was put at (A).
Partial Response
Table 3 presents information on four patients with squa-
mous cell carcinoma (cases 10, 11, 12, and 13) who had
only a partial response to laser hyperthermia. They were
given external beam radiation after laser hyperthermia
failed to eradicate the cancer. As shown in Table 3, these162 R. ONO
four patients showed no local recurrence after a follow-
up period ranging from 6 to 24 months (mean, 11.8
months). Two patients (cases 12 and 13) died ofmyocar-
dial infarction, 7 and 10 months after laser hyperthermia,
respectively. One patient (case 10) was found at autopsy
to have evidence of widespread metastatic disease.
However, there was no evidence of recurrence at the
treated site in the fight main bronchus. At the last follow-
up, the remaining patient (case 11) was alive with no local
recurrence, and the most recent bronchoscopic examina-
tion in this case showed no evidence of residual cancer.
Roentgenographic Appearance and Tumor Size
Of the 13 cancers, 7 that were not visible on the chest
roentgenogram showed a complete response to laser hy-
perthermia. The remaining 6 cancers were large enough
to be detected on the chest roentgenogram. None of these
lesions were associated with a complete response.
The overall surface area was estimated by the bron-
choscopist at the time of the initial laser hyperthermia.
However, the overall surface area of tumor occluding the
bronchus couldnotbe estimated correctly. Therewere two
cases (6 and 8) with polypoid tumor in segmental bronchi
that could be detected as secondary changes radiologi-
cally. Of the 9 cancers that were 3 cm2 or smaller in sur-
face area, a complete response was achieved in all. Of the
4 lesions thatexceeded4cm2 in surface area, nonedemon-
strated a complete response.
Complications
During the initial phase of the study, all patients reported
the developmentofcough productive ofblood-tinged spu-
tum and gray necrotic material. This complication per-
sisted for up to 2 weeks after treatment. Five patients had
fever, pneumonia, excessivebronchial secretions, andmu-
cosal plugging. Three patients experienced temporary air-
way obstruction that was caused by the necrotic debris.
The necrotic debris was removed by flexible fiberoptic
bronchoscopy. One patient (case 2) developed severe can-
didiasis at the treated situ on the tracheal wall. This pa-
tient died after an episode of hemoptysis caused by
internal perforation. The postmortem examination
showed residual necrotic debris and tracheal edema. No
viable cancer cells were identified in the treated site in the
tracheal wall. This patient had had previous cancer of a
different histologic type and was found to have evidence
of widespread metastasis of the first cancer.
DISCUSSION
Laser hyperthermia is a new addition to standard treat-
ment modalities such as surgical resection, radiation ther-
apy, and chemotherapy for patients with bronchogenic
carcinoma. The role oflaserhyperthermia is limited to tu-
mors within the bronchial wall because the depth of pen-
etration of the activating light is no more than 2 cm and
Table 2 Profile of patients who had a complete response after laser hyperthermia
Tumor
Cell type; Surface area No. of
Case Age, Sex Site (cm2) treatments
Power
Density Light Dose
W/cm J/cm
60,m Squamous; trachea 2
2 68,m Adeno-carcinoma;
3 2
3 70,m trachea 3
squamous; <
RB2 2
4 36,e squamous; 1-2
trachea 2
5 69,m Squamous; 1-2
trachea 2
6 66,m Squamous; <
LB 10
7 68,m Squamous;
trachea 3 2
3
8 67,m Squamous; 2-3
LB8 2
9 68,m Squamous; 3 2
RML 3
2 2278
2 2223
3 1790
3 2973
3 1497
2 1180
2 2441
3 2223
3 1648
3 2535
3 1043
2 3832
3 3181
3 2622
3 3123
3 2932
3 1003
3 1666
3 1324
Note. L.T. indicates laser hyperthermia; RB2, posterior segment of right upper lobe; LB 10, posterior basilar segment of left lower lobe; LB8,
anterior basilar segment of left lower lobe; and RML, right middle lobe.BRONCHOSCOPIC LASER HYPERTHERMIA 163
Figure 2 Squamous cell carcinoma in the spur region ofthe right upper
lobe bronchus before and after laser hyperthermia
is probably much less than cm. Therefore, the main ap-
plication is in the treatment of carcinoma in situ or intra-
mural invasive tumor. The likelihood of lymph node
metastasis from these types of tumors is low (7, 8).
In our study, seven out of nine cancers with a complete
response after laser hyperthermia were roentgenographi-
cally occult tumors less than 3 cm2 in surface area and
within the reach of the flexible fiberoptic bronchoscope.
One patient (case 2) died of hemoptysis after treatment.
This patient had a squamous cell carcinoma in the right
lung that was resected, but afterward an adenocarcinoma
was detected in the lower part of trachea. Laser hyper-
thermia was performed three times, obtaining complete
response; however, the patient died of hemoptysis caused
by perforation after 4 months. There was no evidence of
recurrence at autopsy, but the death was considered to have
caused by this treatment.
No other serious complications were experienced, apart
from three cases of transient airway obstruction caused by
necrotic debris. We recommend that a clean-up bron-
choscopy should be performed to remove the secretions
within or 2 days after treatment, whether or not symp-
toms occur. Hayata and Kato et al (9) also routinely per-
form a clean-up bronchoscopy or 2 days after HpD
photodynamic therapy. They have reported excellent re-
suits in patients with early lung cancer. There have been
few reports on laser hyperthermia for lung cancer (10).
We began to investigate local endoscopic thermal treat-
ment for the application ofcontactNd:YAG laser core rod
type probe using low-grade capacity. Experiments on the
normal dog bronchus using a local thermal beam showed
extensive histologic changes in the submucosal layer. The
thickness was parallel to the capacity, but there was little
difference in submucosal change.We feltthat itwas proper
for local thermal treatment to use low energy under 5 watts
to have a good effect. Because upgrade of local tissue,
thermal energy was counted on the point of 50C in the
center area under temperature control at 42.0C + 1.0C
at the point of 5.0-mm distance from the inserted probe,
the thermister was placed 5.0 mm from the probe to con-
firm the temperature in operation. It was, necessary, there-
fore, to use a double-channel bronchoscope to insert the
probe and thermister separately on the treatment site.
This was kept on up to 40C after stopping the beam,
but this required that a broader area be maintained or sup-
ported for a longer period under the temperature of42.5C
for thermal treatment.
To date, nothing has been developed for local thermal
restraint. This report is the first description of computer
controlled local Nd:YAG laser hyperthermia. As a result
of this investigation, a core rod-type probe power density
is considered to be appropriate for local thermal treatment.
Considering the thermal change by the cooling effect in
living tissue organ, examination of beam’s condition
against the tumor is more effective in exploiting high-
grade spreading of the contact terminal. Finally the de-
velopment of an apparatus capable of easy clinical
application and of providing an effective laser beam with
a tissue thermometer are required.
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